Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06564831 · ClinicalTrials.gov registry record · NA
Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care
A NA study of Diabetic Foot Ulcer and Diabetic Foot, sponsored by Applied Biologics.
- Recruiting
- Registry status
- NA
- Development phase
- 124
- Enrollment target
- 1
- Study location
NCT06564831 is a NA study of Diabetic Foot Ulcer and Diabetic Foot that is actively recruiting participants, run by Applied Biologics. The registered enrollment target is 124 participants, below the 253-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06564831, a NA study of Diabetic Foot Ulcer and Diabetic Foot, is actively recruiting participants, sponsored by Applied Biologics.
- RECRUITING
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
- 1
- Study location
Study Summary
A Randomized Controlled Multicenter Clinical Trial, Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care versus Standard of Care alone in the management of Nonhealing Diabetic Foot Ulcers
Conditions Studied
Interventions
- OTHER SOC
- OTHER SLAM + SOC
Study Locations (1)
Michigan
- Detroit Foot and Ankle - Clinton Township
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2024-09-20 |
| Est. Completion | 2025-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06564831
The ClinicalTrials.gov registry entry for NCT06564831 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 253-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (51% lower). The listed sponsor is Applied Biologics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 2 interventions - of which SOC is the first listed.
NCT06564831 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT06564831 about?
NCT06564831 is a clinical study titled "Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care". A Randomized Controlled Multicenter Clinical Trial, Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care versus Standard of Care alone in the management of Nonhealing Diabetic Foot Ulcers
What is the current status of trial NCT06564831?
This trial is currently recruiting. It is a NA study. The enrollment target is 124 participants. The study started on 2024-09-20. Estimated completion is 2025-08.
What conditions does trial NCT06564831 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Diabetic Foot, Foot Ulcer, Ulcer Foot, DFU.
What interventions are being tested in trial NCT06564831?
The interventions under investigation include: SOC (OTHER), SLAM + SOC (OTHER).
Who is sponsoring clinical trial NCT06564831?
This trial is sponsored by Applied Biologics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06564831 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.